UK markets closed

GlaxoSmithKline plc (GSK)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
43.69+0.94 (+2.20%)
At close: 04:00PM EDT
43.43 -0.26 (-0.60%)
After hours: 07:38PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 105.35B
Enterprise value 129.05B
Trailing P/E 16.93
Forward P/E 13.85
PEG ratio (5-yr expected) 1.80
Price/sales (ttm)2.38
Price/book (mrq)5.37
Enterprise value/revenue 3.54
Enterprise value/EBITDA 12.87

Trading information

Stock price history

Beta (5Y monthly) 0.29
52-week change 39.55%
S&P500 52-week change 3-8.83%
52-week high 346.97
52-week low 337.80
50-day moving average 344.00
200-day moving average 342.73

Share statistics

Avg vol (3-month) 35.66M
Avg vol (10-day) 36.62M
Shares outstanding 52.54B
Implied shares outstanding 6N/A
Float 82.45B
% held by insiders 10.03%
% held by institutions 113.50%
Shares short (30 May 2022) 45.09M
Short ratio (30 May 2022) 40.85
Short % of float (30 May 2022) 4N/A
Short % of shares outstanding (30 May 2022) 40.20%
Shares short (prior month 28 Apr 2022) 47.35M

Dividends & splits

Forward annual dividend rate 41.99
Forward annual dividend yield 44.55%
Trailing annual dividend rate 30.75
Trailing annual dividend yield 31.75%
5-year average dividend yield 45.23
Payout ratio 478.63%
Dividend date 330 Jun 2022
Ex-dividend date 418 May 2022
Last split factor 22:1
Last split date 311 Nov 1991

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022

Profitability

Profit margin 14.02%
Operating margin (ttm)23.40%

Management effectiveness

Return on assets (ttm)6.36%
Return on equity (ttm)27.51%

Income statement

Revenue (ttm)36.48B
Revenue per share (ttm)14.56
Quarterly revenue growth (yoy)31.80%
Gross profit (ttm)22.66B
EBITDA 10.82B
Net income avi to common (ttm)5.11B
Diluted EPS (ttm)2.47
Quarterly earnings growth (yoy)67.90%

Balance sheet

Total cash (mrq)13.98B
Total cash per share (mrq)5.56
Total debt (mrq)33.35B
Total debt/equity (mrq)147.36
Current ratio (mrq)1.19
Book value per share (mrq)6.43

Cash flow statement

Operating cash flow (ttm)10.16B
Levered free cash flow (ttm)7.01B